Breaking News Bar

Business News and Information

The Rosen Law Firm Announces Investigation of Jiangbo Pharmaceuticals, Inc.

The Rosen Law Firm, P.A. announces that it is investigating potential securities claims against Jiangbo Pharmaceuticals, Inc. (NASDAQ: JGBO) resulting from allegations that the company may have issued materially misleading statements and business information to the investing public.

The Rosen Law Firm is investigating the circumstances surrounding the resignation of certain of the Company’s personnel and the Company’s internal investigation. These adverse events appear to have prompted the halt in trading of the Company’s common stock since May 31, 2011.

The Rosen Law Firm is preparing a securities class action lawsuit on behalf of Jiangbo Pharmaceuticals investors to recover their investment losses. If you purchased Jiangbo stock, please visit the website at to participate in the class action and to obtain more information. You may also contact Phillip Kim of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.


The Rosen Law Firm P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
275 Madison Avenue 34th Floor
New York, New York 10016
Tel: 212-686-1060
Weekends Tel: 917-797-4425
Toll Free: 1-866-767-3653
Fax: 212-202-3827

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear